Target intelligence / Profile preview

PDZ domain containing ring finger protein 3 (PDZRN3)

Target
PDZRN3
Molecular classification
Ligand of Numb protein-X (LNX) family member, RING-type ubiquitin E3 ligase, PDZ domain-containing protein, Other (multifunctional scaffolding/adaptor protein)
01

Overview

PDZ domain containing ring finger protein 3 (PDZRN3) is a multifunctional scaffolding protein and E3 ubiquitin ligase expressed in multiple human tissues, including muscle and endothelium. PDZRN3 regulates cell differentiation, apoptosis, and proliferation by mediating the ubiquitination and proteasomal degradation of target proteins such as MUSK and β-catenin. It modulates canonical Wnt signaling and is implicated in the progression and metastasis of various cancer types, notably endometrial carcinoma, where its low expression correlates with poorer patient outcomes. PDZRN3 is under investigation as a biomarker and potential therapeutic target, with functional roles in vascular development, neurogenesis, and tissue morphogenesis documented in both experimental and clinical studies.

Other names
PDZRN3LNX3SEMAPCAP3SEMCAP3
02

Mechanism of action

Drugs (potential or hypothetical) would likely act by modulating its E3 ubiquitin ligase activity, affecting ubiquitination and degradation of downstream proteins (such as MUSK or β-catenin). Modulation of Wnt/β-catenin signaling pathway: targeting PDZRN3 may attenuate cancer cell proliferation and metastasis.

03

Biological functions

Cell differentiation (myoblasts, osteoblasts, adipocytes)Vascular morphogenesisUbiquitination (modifies other proteins, especially MUSK)Regulation of cell proliferation and apoptosisMaintenance of endothelial junctionsRegulation of canonical Wnt signaling pathway
04

Disease associations

Cancer (e.g., endometrial carcinoma, prostate cancer)Childhood-onset schizophreniaOther (possible roles in development and neurogenesis per animal models)
05

Safety considerations

No safety concerns are documented; as with other ubiquitin ligases, targeting PDZRN3 could potentially affect normal cell differentiation and viabilityBiological role in maintenance of tissue differentiation and vascular integrity suggests possible off-target effects if inhibited systemically
06

Interacting drugs

None explicitly identified in available sources; PDZRN3 is under basic research as a therapeutic target
07

Biomarkers

PDZRN3 expression level (for prognosis or monitoring progression in endometrial carcinoma and possibly other cancers)

Beyond the preview

Go deeper on PDZ domain containing ring finger protein 3 (PDZRN3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PDZ domain containing ring finger protein 3 (PDZRN3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call